GenIP ® launched its Initial Public Offering on 2 October 2024, raising £1.75 million to develop its corporate strategy. Tekcapital, through its subsidiary Tekcapital Europe, now holds 64% of the issued share capital of GenIP. It has long been a supportive stakeholder in all its IPOs including the successful MicroSalt launch earlier this year. GenIP ® provides artificial intelligence analytic services to help various companies, research institutions and venture funds to assess and commercialise new discoveries. It does this by combining expert human technical review with GenAI algorithms to provide insightful services that function better than human work alone. It’s also applying AI tech to recruiting with great success. With its recent transition to AI-enhanced services and strong initial sales traction, GenIP ® presents an attractive investment opportunity in the high-growth artificial intelligence sector.
Download your report now for instant access. Exclusively aimed at UK resident persons who are required to self-certify as either a Sophisticated Investor or High Net Worth Individuals.
Download Report
Please read the High Net Worth Individual Statement or Sophisticated Investor Statement before downloading this guide.